These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14518210)

  • 1. [Detection of hepatic micrometastasis in ductal pancreatic carcinoma by K-ras mutation analysis and determination of clinical relevance].
    Bastian D; Gerdes B; Ramaswamy A; Tschammer C; Bartsch D
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):45-7. PubMed ID: 14518210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
    Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
    JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma.
    Tamagawa E; Ueda M; Takahashi S; Sugano K; Uematsu S; Mukai M; Ogata Y; Kitajima M
    Clin Cancer Res; 1997 Nov; 3(11):2143-9. PubMed ID: 9815608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras mutation in focal proliferative lesions of human pancreas.
    Terhune PG; Phifer DM; Tosteson TD; Longnecker DS
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):515-21. PubMed ID: 9641496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
    Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
    Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.
    Mulcahy HE; Lyautey J; Lederrey C; qi Chen X; Anker P; Alstead EM; Ballinger A; Farthing MJ; Stroun M
    Clin Cancer Res; 1998 Feb; 4(2):271-5. PubMed ID: 9516910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates.
    Pabst B; Arps S; Binmoeller K; Thul R; Walsemann G; Fenner C; Klapdor R
    Anticancer Res; 1999; 19(4A):2481-3. PubMed ID: 10470178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
    Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
    J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiment study on the diagnostic value of bile K-ras gene mutation responsible to the hepatic metastasis of pancreatic cancer].
    Zhou X; Zhang ZD; Tian BL; Han FH; Hu WM; Jia W; Lu HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):309-11, 327. PubMed ID: 17441357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].
    Dai MH; Zhao YP; Cai LX; Zhu Y
    Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):332-5. PubMed ID: 12892584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [K-ras mutations detection in paraaortic lymph nodes and its prognostic value after the surgical treatment of pancreas cancer].
    Agaev BA; Muslimov GF; Iagublu VSh; Babaeva NR
    Khirurgiia (Mosk); 2008; (9):64-9. PubMed ID: 18833187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic liver metastases after curative resection combined with intraoperative radiation for pancreatic cancer.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T
    Hepatogastroenterology; 2004; 51(59):1500-3. PubMed ID: 15362786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: prognostic implications.
    Schimanski CC; Linnemann U; Galle PR; Arbogast R; Berger MR
    Int J Oncol; 2003 Sep; 23(3):791-6. PubMed ID: 12888919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of bile for the detection of mutant K-ras from colorectal liver metastases.
    de Kok JB; Swinkels DW; Ruers TJ
    Anticancer Res; 2000; 20(4):2469-72. PubMed ID: 10953312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
    Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.